RadNet, Inc. (RDNT)
USD 47.36
(-4.86%)
USD 47.36
(-4.86%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.07 Billion USD | 6.74% |
| 2022 | 1.94 Billion USD | 13.44% |
| 2021 | 1.71 Billion USD | 12.04% |
| 2020 | 1.52 Billion USD | 8.2% |
| 2019 | 1.41 Billion USD | 55.37% |
| 2018 | 909.07 Million USD | 13.77% |
| 2017 | 799.05 Million USD | 0.2% |
| 2016 | 797.42 Million USD | -0.57% |
| 2015 | 801.97 Million USD | 9.41% |
| 2014 | 732.98 Million USD | 1.75% |
| 2013 | 720.36 Million USD | 0.45% |
| 2012 | 717.12 Million USD | 4.08% |
| 2011 | 688.99 Million USD | 10.77% |
| 2010 | 621.98 Million USD | 11.98% |
| 2009 | 555.43 Million USD | -3.67% |
| 2008 | 576.6 Million USD | 14.58% |
| 2007 | 503.24 Million USD | 139.46% |
| 2006 | 210.16 Million USD | 9.53% |
| 2005 | 191.86 Million USD | -1.61% |
| 2004 | 195 Million USD | 0.27% |
| 2003 | 194.48 Million USD | -3.27% |
| 2002 | 201.05 Million USD | 16.27% |
| 2001 | 172.92 Million USD | 14.49% |
| 2000 | 151.03 Million USD | 11.06% |
| 1999 | 136 Million USD | 15.9% |
| 1998 | 117.34 Million USD | 6.83% |
| 1997 | 109.83 Million USD | -15.15% |
| 1996 | 129.45 Million USD | 59.86% |
| 1995 | 80.97 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.89 Billion USD | -8.73% |
| 2024 Q2 | 2.13 Billion USD | 12.91% |
| 2023 Q1 | 1.92 Billion USD | -1.11% |
| 2023 FY | 2.07 Billion USD | 6.74% |
| 2023 Q4 | 2.07 Billion USD | 9.59% |
| 2023 Q2 | 1.94 Billion USD | 1.21% |
| 2023 Q3 | 1.89 Billion USD | -2.7% |
| 2022 Q4 | 1.94 Billion USD | 8.59% |
| 2022 FY | 1.94 Billion USD | 13.44% |
| 2022 Q3 | 1.78 Billion USD | -0.03% |
| 2022 Q2 | 1.78 Billion USD | 4.03% |
| 2022 Q1 | 1.72 Billion USD | 0.45% |
| 2021 FY | 1.71 Billion USD | 12.04% |
| 2021 Q4 | 1.71 Billion USD | 0.55% |
| 2021 Q3 | 1.7 Billion USD | -1.73% |
| 2021 Q1 | 1.54 Billion USD | 1.25% |
| 2021 Q2 | 1.73 Billion USD | 11.99% |
| 2020 Q2 | 1.48 Billion USD | -0.57% |
| 2020 FY | 1.52 Billion USD | 8.2% |
| 2020 Q1 | 1.49 Billion USD | 5.65% |
| 2020 Q4 | 1.52 Billion USD | 3.85% |
| 2020 Q3 | 1.47 Billion USD | -0.81% |
| 2019 Q1 | 1.31 Billion USD | 44.38% |
| 2019 FY | 1.41 Billion USD | 55.37% |
| 2019 Q2 | 1.38 Billion USD | 5.46% |
| 2019 Q3 | 1.4 Billion USD | 1.34% |
| 2019 Q4 | 1.41 Billion USD | 0.69% |
| 2018 Q4 | 909.07 Million USD | 15.17% |
| 2018 FY | 909.07 Million USD | 13.77% |
| 2018 Q1 | 807.26 Million USD | 1.03% |
| 2018 Q2 | 788.05 Million USD | -2.38% |
| 2018 Q3 | 789.35 Million USD | 0.17% |
| 2017 FY | 799.05 Million USD | 0.2% |
| 2017 Q4 | 799.05 Million USD | 3.24% |
| 2017 Q3 | 773.96 Million USD | -1.8% |
| 2017 Q2 | 788.17 Million USD | -1.59% |
| 2017 Q1 | 800.87 Million USD | 0.43% |
| 2016 Q3 | 803.05 Million USD | 1.48% |
| 2016 Q4 | 797.42 Million USD | -0.7% |
| 2016 Q2 | 791.37 Million USD | -2.08% |
| 2016 Q1 | 808.17 Million USD | 0.77% |
| 2016 FY | 797.42 Million USD | -0.57% |
| 2015 Q1 | 735.86 Million USD | 0.39% |
| 2015 Q2 | 776.31 Million USD | 5.5% |
| 2015 Q4 | 801.97 Million USD | 2.48% |
| 2015 FY | 801.97 Million USD | 9.41% |
| 2015 Q3 | 782.53 Million USD | 0.8% |
| 2014 Q3 | 745.9 Million USD | 0.63% |
| 2014 FY | 732.98 Million USD | 1.75% |
| 2014 Q4 | 732.98 Million USD | -1.73% |
| 2014 Q2 | 741.2 Million USD | -0.72% |
| 2014 Q1 | 746.56 Million USD | 3.64% |
| 2013 Q2 | 721.79 Million USD | -0.51% |
| 2013 Q4 | 720.36 Million USD | 0.78% |
| 2013 FY | 720.36 Million USD | 0.45% |
| 2013 Q1 | 725.52 Million USD | 1.17% |
| 2013 Q3 | 714.77 Million USD | -0.97% |
| 2012 FY | 717.12 Million USD | 4.08% |
| 2012 Q3 | 684.25 Million USD | -1.2% |
| 2012 Q2 | 692.56 Million USD | -0.32% |
| 2012 Q1 | 694.81 Million USD | 0.84% |
| 2012 Q4 | 717.12 Million USD | 4.8% |
| 2011 Q1 | 638.41 Million USD | 2.64% |
| 2011 Q3 | 648.41 Million USD | 0.04% |
| 2011 FY | 688.99 Million USD | 10.77% |
| 2011 Q4 | 688.99 Million USD | 6.26% |
| 2011 Q2 | 648.13 Million USD | 1.52% |
| 2010 Q2 | 617.33 Million USD | 12.24% |
| 2010 Q3 | 625.17 Million USD | 1.27% |
| 2010 FY | 621.98 Million USD | 11.98% |
| 2010 Q4 | 621.98 Million USD | -0.51% |
| 2010 Q1 | 549.99 Million USD | -0.98% |
| 2009 Q3 | 554.62 Million USD | -0.91% |
| 2009 Q4 | 555.43 Million USD | 0.14% |
| 2009 Q1 | 576.06 Million USD | -0.09% |
| 2009 Q2 | 559.71 Million USD | -2.84% |
| 2009 FY | 555.43 Million USD | -3.67% |
| 2008 Q2 | 586.39 Million USD | 1.75% |
| 2008 FY | 576.6 Million USD | 14.58% |
| 2008 Q3 | 591.78 Million USD | 0.92% |
| 2008 Q4 | 576.6 Million USD | -2.57% |
| 2008 Q1 | 576.28 Million USD | 14.51% |
| 2007 Q2 | 442.19 Million USD | -0.55% |
| 2007 Q1 | 444.65 Million USD | 0.0% |
| 2007 Q3 | 487.03 Million USD | 10.14% |
| 2007 Q4 | 503.24 Million USD | 3.33% |
| 2007 FY | 503.24 Million USD | 139.46% |
| 2006 Q3 | 210.16 Million USD | 4.47% |
| 2006 FY | 210.16 Million USD | 9.53% |
| 2006 Q2 | 201.16 Million USD | 2.41% |
| 2006 Q1 | 196.44 Million USD | 3.64% |
| 2005 Q3 | 191.86 Million USD | -0.53% |
| 2005 FY | 191.86 Million USD | -1.61% |
| 2005 Q4 | 189.54 Million USD | -1.21% |
| 2005 Q2 | 192.89 Million USD | -1.45% |
| 2005 Q1 | 195.72 Million USD | 0.17% |
| 2004 Q4 | 195.4 Million USD | 0.2% |
| 2004 Q1 | 195.73 Million USD | -0.69% |
| 2004 Q3 | 195 Million USD | -0.31% |
| 2004 Q2 | 195.62 Million USD | -0.06% |
| 2004 FY | 195 Million USD | 0.27% |
| 2003 Q2 | 198.17 Million USD | -2.03% |
| 2003 FY | 194.48 Million USD | -3.27% |
| 2003 Q3 | 194.48 Million USD | -1.86% |
| 2003 Q1 | 202.28 Million USD | -1.88% |
| 2003 Q4 | 197.09 Million USD | 1.34% |
| 2002 FY | 201.05 Million USD | 16.27% |
| 2002 Q4 | 206.17 Million USD | 2.55% |
| 2002 Q3 | 201.05 Million USD | 0.97% |
| 2002 Q2 | 199.11 Million USD | 5.02% |
| 2002 Q1 | 189.59 Million USD | 3.65% |
| 2001 Q1 | 149.76 Million USD | -0.59% |
| 2001 FY | 172.92 Million USD | 14.49% |
| 2001 Q4 | 182.91 Million USD | 5.77% |
| 2001 Q3 | 172.92 Million USD | 10.94% |
| 2001 Q2 | 155.87 Million USD | 4.08% |
| 2000 Q1 | 140.2 Million USD | 0.22% |
| 2000 Q4 | 150.65 Million USD | -0.25% |
| 2000 Q3 | 151.03 Million USD | 1.99% |
| 2000 Q2 | 148.08 Million USD | 5.63% |
| 2000 FY | 151.03 Million USD | 11.06% |
| 1999 Q1 | 129.9 Million USD | 3.51% |
| 1999 Q4 | 139.9 Million USD | 2.57% |
| 1999 FY | 136 Million USD | 15.9% |
| 1999 Q3 | 136.4 Million USD | 4.12% |
| 1999 Q2 | 131 Million USD | 0.85% |
| 1998 FY | 117.34 Million USD | 6.83% |
| 1998 Q3 | 117.8 Million USD | 3.42% |
| 1998 Q2 | 113.9 Million USD | 0.89% |
| 1998 Q1 | 112.9 Million USD | 1.62% |
| 1998 Q4 | 125.5 Million USD | 6.54% |
| 1997 Q1 | 115.6 Million USD | -12.69% |
| 1997 FY | 109.83 Million USD | -15.15% |
| 1997 Q4 | 111.1 Million USD | -0.18% |
| 1997 Q2 | 120.7 Million USD | 4.41% |
| 1997 Q3 | 111.3 Million USD | -7.79% |
| 1996 Q4 | 132.4 Million USD | 1.22% |
| 1996 Q3 | 130.8 Million USD | 48.97% |
| 1996 FY | 129.45 Million USD | 59.86% |
| 1996 Q2 | 87.8 Million USD | -0.34% |
| 1996 Q1 | 88.1 Million USD | 0.0% |
| 1995 FY | 80.97 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 40.22 Million USD | -5054.214% |
| Applied DNA Sciences, Inc. | 8.77 Million USD | -23516.528% |
| Aspira Women's Health Inc. | 8.62 Million USD | -23933.082% |
| Biodesix, Inc. | 94.51 Million USD | -2093.633% |
| BioNexus Gene Lab Corp. | 1.74 Million USD | -118924.353% |
| bioAffinity Technologies, Inc. | 3.36 Million USD | -61490.941% |
| bioAffinity Technologies, Inc. | 3.36 Million USD | -61490.941% |
| Bionano Genomics, Inc. | 118.24 Million USD | -1653.392% |
| CareDx, Inc | 223.28 Million USD | -828.551% |
| Check-Cap Ltd. | 1.33 Million USD | -155789.774% |
| Castle Biosciences, Inc. | 86.54 Million USD | -2295.755% |
| DarioHealth Corp. | 38.24 Million USD | -5321.19% |
| Exact Sciences Corporation | 3.32 Billion USD | 37.663% |
| Fulgent Genetics, Inc. | 139.82 Million USD | -1382.828% |
| Guardant Health, Inc. | 1.62 Billion USD | -27.375% |
| ICON Public Limited Company | 7.74 Billion USD | 73.244% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -16.782% |
| Illumina, Inc. | 4.36 Billion USD | 52.512% |
| Intelligent Bio Solutions Inc. | 5.59 Million USD | -36952.458% |
| iSpecimen Inc. | 6.07 Million USD | -34011.772% |
| Standard BioTools Inc. | 159.86 Million USD | -1196.928% |
| MDxHealth SA | 121.92 Million USD | -1600.513% |
| 23andMe Holding Co. | 206.64 Million USD | -903.322% |
| Medpace Holdings, Inc. | 1.09 Billion USD | -88.849% |
| Myriad Genetics, Inc. | 312.9 Million USD | -562.619% |
| Mainz Biomed B.V. | 12.15 Million USD | -16950.722% |
| ENDRA Life Sciences Inc. | 1.09 Million USD | -189218.426% |
| NeoGenomics, Inc. | 739.69 Million USD | -180.297% |
| Neogen Corporation | 1.44 Billion USD | -43.98% |
| Inotiv, Inc. | 588.04 Million USD | -252.584% |
| Natera, Inc. | 691.79 Million USD | -199.702% |
| OpGen, Inc. | 13.44 Million USD | -15322.165% |
| OPKO Health, Inc. | 622.47 Million USD | -233.077% |
| Psychemedics Corporation | 6.59 Million USD | -31323.674% |
| Prenetics Global Limited | 44.01 Million USD | -4610.704% |
| Prenetics Global Limited | 44.01 Million USD | -4610.704% |
| Precipio, Inc. | 3.67 Million USD | -56363.344% |
| Personalis, Inc. | 95.65 Million USD | -2067.444% |
| Sera Prognostics, Inc. | 25.28 Million USD | -8100.506% |
| Sotera Health Company | 2.68 Billion USD | 22.829% |
| Neuronetics, Inc. | 81.64 Million USD | -2439.574% |
| Star Equity Holdings, Inc. | 21.67 Million USD | -9465.555% |
| Star Equity Holdings, Inc. | 21.67 Million USD | -9465.555% |
| Trinity Biotech plc | 83.38 Million USD | -2386.489% |
| T2 Biosystems, Inc. | 62.83 Million USD | -3199.753% |
| Twist Bioscience Corporation | 152.97 Million USD | -1255.377% |
| Exagen Inc. | 34.25 Million USD | -5953.53% |